The chairman of the European Medicines Agency’s main committee for approving new drugs resigned suddenly on Wednesday, in a move a spokesman said was related to his position at the French healthcare regulator, AFSSAPS. Eric Abadie’s resignation as chairman of the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) is effective immediately. The spokesman for Europe’s equivalent of the U.S. Food and Drug Administration said the Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSAPS) was expected to issue a statement on Thursday, also regarding Abadie’s position.
